Lenalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients: Meta-analysis of Efficacy in Pivotal Randomized Controlled Trials

被引：0
|
作者：
Manier, Salomon [1 ]
Robinson, Suzanne [2 ]
Owen, Melody [3 ]
Dhanasiri, Sujith [2 ]
Frederickson, Andrew [3 ]
Jackson, Graham [4 ]
Facon, Thierry [1 ]
机构：
[1] CHU Lille, Dept Haematol, Lille, France
[2] Celgene Corp, Summit, NJ USA
[3] Precis Xtract, Oakland, CA USA
[4] NCCC Freeman Hosp, Clin Haematol, Newcastle Upon Tyne, Tyne & Wear, England
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
meta-analysis; Multiple myeloma;
D O I：
10.1016/j.clml.2019.09.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OAB-012
引用
收藏
页码：E9 / E10
页数：2
相关论文
共 50 条
  • [1] Combination therapy with lenalidomide and dexamethasone for multiple myeloma: a meta-analysis of phase III randomized controlled trials
    Kong, Yuanyuan
    Hu, Liangning
    Chen, Gege
    Wang, Houcai
    Yang, Guang
    Gao, Minjie
    Wu, Xiaosong
    Zhang, Yiwen
    Zhan, Fenghuang
    Dai, Bojie
    Shi, Jumei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 10838 - 10846
  • [2] Comparing efficacy and survivals of initial treatments for elderly patients with newly diagnosed multiple myeloma: a network meta-analysis of randomized controlled trials
    Liu, Xiaoping
    Chen, Jiarui
    He, Yuncen A.
    Meng, Xiangyu
    Li, Kaili
    He, Colin K.
    Liu, Shangqin
    ONCOTARGETS AND THERAPY, 2017, 10 : 121 - 128
  • [3] Efficacy and Safety of Lenalidomide in the Treatment of Multiple Myeloma: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Qiao, Shu-Kai
    Guo, Xiao-Nan
    Ren, Jin-Hai
    Ren, Han-Yun
    CHINESE MEDICAL JOURNAL, 2015, 128 (09) : 1215 - 1222
  • [4] Efficacy and Safety of Lenalidomide in the Treatment of Multiple Myeloma: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Qiao Shu-Kai
    Guo Xiao-Nan
    Ren Jin-Hai
    Ren Han-Yun
    中华医学杂志英文版, 2015, 128 (09) : 1215 - 1222
  • [5] Comparative efficacy of carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) in newly-diagnosed multiple myeloma: A systematic review and meta-analysis
    Costa, Bruno Almeida
    Costa, Thomaz Alexandre
    Pak, Kevin
    Patel, Aesha
    Felix, Nicole
    Mouhieddine, Tarek H.
    Richter, Joshua
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (07) : 1411 - 1414
  • [6] Lenalidomide Treatment for Multiple Myeloma: Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Yang, Bo
    Yu, Rui-li
    Chi, Xiao-hua
    Lu, Xue-chun
    PLOS ONE, 2013, 8 (05):
  • [7] (Bortezomib plus lenalidomide/thalidomide)- vs (bortezomib or lenalidomide/thalidomide)-containing regimens as induction therapy in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials
    Wang, Anyou
    Duan, Qiaohong
    Liu, Xin
    Ding, Kaiyang
    Han, Yongsheng
    Zhu, Weibo
    Cai, Xiaoyan
    Wu, Jingsheng
    Sun, Zimin
    ANNALS OF HEMATOLOGY, 2012, 91 (11) : 1779 - 1784
  • [8] (Bortezomib plus lenalidomide/thalidomide)- vs (bortezomib or lenalidomide/thalidomide)-containing regimens as induction therapy in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials
    Anyou Wang
    Qiaohong Duan
    Xin Liu
    Kaiyang Ding
    Yongsheng Han
    Weibo Zhu
    Xiaoyan Cai
    Jingsheng Wu
    Zimin Sun
    Annals of Hematology, 2012, 91 : 1779 - 1784
  • [9] Comparative Efficacy of Carfilzomib, Lenalidomide and Dexamethasone (KRD) Vs. Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRD) in Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis
    Wang, Yuqi
    Huan, Chen
    Hanzhen, Zhang
    Zhang, Shanshan
    Yuan, Youhai
    Feng, Ru
    Wei, Yongqiang
    Wei, Xiaolei
    BLOOD, 2024, 144 : 7031 - 7031
  • [10] Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma
    Rosinol, Laura
    Hebraud, Benjamin
    Oriol, Albert
    Colin, Anne-Laurene
    Tamayo, Rafael Rios
    Hulin, Cyrille
    Blanchard, Maria Jesus
    Caillot, Denis
    Sureda, Anna
    Hernandez, Miguel Teodoro
    Arnulf, Bertrand
    Mateos, Maria-Victoria
    Macro, Margaret
    San-Miguel, Jesus
    Belhadj, Karim
    Lahuerta, Juan Jose
    Garelik, M. Brigid
    Blade, Joan
    Moreau, Philippe
    FRONTIERS IN ONCOLOGY, 2023, 13
12345